359 related articles for article (PubMed ID: 34210299)
1. Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers.
Zenone MA; Snyder J; Crooks V
BMC Public Health; 2021 Jul; 21(1):1285. PubMed ID: 34210299
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
3. CBD Retailers in NC Promote CBD Online to Treat Pain Violating FDA Rules About Medical Claims and Offer Low-CBD/High-Price Products.
Amann L; Kruse E; Lazard AJ; Reboussin BA; Wagoner KG; Romero-Sandoval EA
J Pain Res; 2022; 15():3847-3858. PubMed ID: 36514481
[TBL] [Abstract][Full Text] [Related]
4. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
Goodman S; Wadsworth E; Schauer G; Hammond D
Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
[No Abstract] [Full Text] [Related]
5. Safety and risks of CBD oils purchased online: unveiling uncertain quality and vague health claims.
Vida RG; Strauss LV; Bajtel Á; Kiss T; Csupor D; Fittler A
Front Pharmacol; 2023; 14():1273540. PubMed ID: 38192407
[No Abstract] [Full Text] [Related]
6. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.
Wagoner KG; Lazard AJ; Romero-Sandoval EA; Reboussin BA
Cannabis Cannabinoid Res; 2021 Dec; 6(6):559-563. PubMed ID: 34142863
[No Abstract] [Full Text] [Related]
7. Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops.
Leas EC; Moy N; McMenamin SB; Shi Y; Benmarhnia T; Stone MD; Trinidad DR; White M
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206501
[TBL] [Abstract][Full Text] [Related]
8. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
Tran T; Kavuluru R
Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
[TBL] [Abstract][Full Text] [Related]
9. Access to cannabidiol without a prescription: A cross-country comparison and analysis.
McGregor IS; Cairns EA; Abelev S; Cohen R; Henderson M; Couch D; Arnold JC; Gauld N
Int J Drug Policy; 2020 Nov; 85():102935. PubMed ID: 32919298
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol (CBD): Perspectives from Pinterest.
Merten JW; Gordon BT; King JL; Pappas C
Subst Use Misuse; 2020; 55(13):2213-2220. PubMed ID: 32715862
[TBL] [Abstract][Full Text] [Related]
12. Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi.
Gurley BJ; Murphy TP; Gul W; Walker LA; ElSohly M
J Diet Suppl; 2020; 17(5):599-607. PubMed ID: 32431186
[TBL] [Abstract][Full Text] [Related]
13. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Claims in Cannabidiol (CBD) Marketing Messages on Twitter.
Soleymanpour M; Saderholm S; Kavuluru R
Proceedings (IEEE Int Conf Bioinformatics Biomed); 2021 Dec; 2021():3083-3088. PubMed ID: 35096472
[TBL] [Abstract][Full Text] [Related]
15. Infodemiological Examination of Personal and Commercial Tweets About Cannabidiol: Term and Sentiment Analysis.
Turner J; Kantardzic M; Vickers-Smith R
J Med Internet Res; 2021 Dec; 23(12):e27307. PubMed ID: 34932014
[TBL] [Abstract][Full Text] [Related]
16. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults.
Wheeler M; Merten JW; Gordon BT; Hamadi H
Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530
[No Abstract] [Full Text] [Related]
17. Cannabis Retailer Communication About Cannabis Products, Health Benefits, and Risks: A Mystery Shopper Study of Licensed Retailers in Five U.S. Cities.
Romm KF; Cavazos-Rehg PA; Williams R; Dopke C; Cui Y; LoParco CR; Wang Y; Duan Z; Yang YT; Burris S; Berg CJ
J Stud Alcohol Drugs; 2024 Jan; 85(1):100-108. PubMed ID: 37917012
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD.
Bhamra SK; Desai A; Imani-Berendjestanki P; Horgan M
Phytother Res; 2021 Oct; 35(10):5734-5740. PubMed ID: 34350641
[TBL] [Abstract][Full Text] [Related]
19. What are the informational pathways that shape people's use of cannabidiol for medical purposes?
Zenone MA; Snyder J; Crooks VA
J Cannabis Res; 2021 May; 3(1):13. PubMed ID: 33957993
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
